Metraipolis › archive › dc_aaa4495a32a3

Price transparency of cancer medicines: a crucial step towards informed pricing negotiations in the European region — Europe PMC PMID:41878331

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41878331
DOI: 10.3389/fphar.2026.1736741
License (as archived): solo-consultazione
Archived: 2026-11-05T00:18:40.507Z
SHA-256 of the archived text: eebc5b842a32114cf41f390122edffa59399f9ebc7c2b0617cd3cc9269ed7ed9
Stable URL of this page: https://metraipolis.com/documento/dc_aaa4495a32a3

How to cite

Price transparency of cancer medicines: a crucial step towards informed pricing negotiations in the European region — Europe PMC PMID:41878331 — Europe PMC (en), https://europepmc.org/article/MED/41878331 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_aaa4495a32a3 (Metraipolis archive dc_aaa4495a32a3, sha256 eebc5b842a32114cf41f390122edffa59399f9ebc7c2b0617cd3cc9269ed7ed9)

BibTeX

@misc{dcaaa4495a32a3,
  title = {Price transparency of cancer medicines: a crucial step towards informed pricing negotiations in the European region — Europe PMC PMID:41878331},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41878331},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_aaa4495a32a3; sha256 eebc5b842a32114cf41f390122edffa59399f9ebc7c2b0617cd3cc9269ed7ed9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41878331. Agents can read the archived copy with the MCP tool read_document.